US Stock MarketDetailed Quotes

ABUS Arbutus Biopharma

Watchlist
  • 3.315
  • -0.005-0.15%
Trading May 7 12:21 ET
634.76MMarket Cap-8.72P/E (TTM)

Arbutus Biopharma Key Stats

Arbutus Biopharma Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CAD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 2.242M--
--2025/Q1-- / 2.287M--
--2024/Q42.245M / 2.208M--
Nov 6, 20242024/Q31.855M / 2.573M--
Aug 1, 20242024/Q22.390M / 2.415M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 2.242M--
--2025/Q1-- / 2.287M--
--2024/Q42.245M / 2.208M--
Nov 6, 20242024/Q31.855M / 2.573M--
Aug 1, 20242024/Q22.390M / 2.415M--

Unlock Free Earnings Estimates

Arbutus Biopharma Earnings Reports

Read more

Market Insights

Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Unlock Now

Discussing

FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma Show More